Miller-Meeks voted YEA on 100% of tracked bills classified by AI as favoring her top donor sectors—Pharmaceuticals & Biotech and Securities & Investment—ranking #32 among House members on this metric. She voted YEA on HR3537-117, the "Accelerating Access to Critical Therapies for ALS Act" classified as favoring pharmaceuticals, and also voted YEA on 3 of 4 bills classified as limiting those same sectors.
FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 3, 2026 · internal signal score 85/100.